The acquisition contributed to 3.1 percent worldwide operational sales growth on the full year. Johnson & Johnson's orthopedics business experienced 60.8 percent sales growth during the fourth quarter and 34 percent sales growth over the entire year in the United States. Worldwide, the company's orthopedics business saw a 64.3 percent sales growth to $2.3 billion in the fourth quarter and 34.3 percent sales growth over the full year to $7.7 billion.
More Articles on Orthopedic Device:
Implant Device Market to Reach $73.9B Value in 2018
6 Potential Effects of the Medical Device Tax on Orthopedics Companies
Zimmer Introduces Its 1st Lateral Plate System for Spinal Trauma
Johnson & Johnson's Synthes Acquisition Adds 5.6% 4Q Sales Growth FeaturedWritten by Laura Miller | January 25, 2013
Johnson & Johnson's acquisition of Sythnes contributed to 5.6 percent to worldwide operational sales growth, net of the divestiture of the DePuy trauma business necessary for the acquisition.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.